These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1537 related items for PubMed ID: 11156424
1. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. Sun SY, Yue P, Hong WK, Lotan R. Cancer Res; 2000 Dec 15; 60(24):7149-55. PubMed ID: 11156424 [Abstract] [Full Text] [Related]
2. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells. Sun SY, Yue P, Lotan R. Oncogene; 2000 Sep 14; 19(39):4513-22. PubMed ID: 11002424 [Abstract] [Full Text] [Related]
3. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells. Sun SY, Yue P, Zhou JY, Wang Y, Choi Kim HR, Lotan R, Wu GS. Biochem Biophys Res Commun; 2001 Jan 26; 280(3):788-97. PubMed ID: 11162590 [Abstract] [Full Text] [Related]
4. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K, Douglas L, Delaney A, Houghton JA. Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455 [Abstract] [Full Text] [Related]
5. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. Liu X, Yue P, Zhou Z, Khuri FR, Sun SY. J Natl Cancer Inst; 2004 Dec 01; 96(23):1769-80. PubMed ID: 15572759 [Abstract] [Full Text] [Related]
6. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK, Lotan R. Cancer Res; 1999 Jun 15; 59(12):2829-33. PubMed ID: 10383141 [Abstract] [Full Text] [Related]
7. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells. Sun SY, Yue P, Chen X, Hong WK, Lotan R. Cancer Res; 2002 Apr 15; 62(8):2430-6. PubMed ID: 11956107 [Abstract] [Full Text] [Related]
8. Defining characteristics of Types I and II apoptotic cells in response to TRAIL. Ozören N, El-Deiry WS. Neoplasia; 2002 Apr 15; 4(6):551-7. PubMed ID: 12407450 [Abstract] [Full Text] [Related]
9. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells. Sun SY, Yue P, Hong WK, Lotan R. Cancer Res; 2000 Nov 15; 60(22):6537-43. PubMed ID: 11103825 [Abstract] [Full Text] [Related]
10. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells. Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK, Lotan R. Oncogene; 1999 Apr 08; 18(14):2357-65. PubMed ID: 10327056 [Abstract] [Full Text] [Related]
11. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460. Huisman C, Ferreira CG, Bröker LE, Rodriguez JA, Smit EF, Postmus PE, Kruyt FA, Giaccone G. Clin Cancer Res; 2002 Feb 08; 8(2):596-606. PubMed ID: 11839682 [Abstract] [Full Text] [Related]
12. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Nimmanapalli R, Perkins CL, Orlando M, O'Bryan E, Nguyen D, Bhalla KN. Cancer Res; 2001 Jan 15; 61(2):759-63. PubMed ID: 11212279 [Abstract] [Full Text] [Related]
13. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Suliman A, Lam A, Datta R, Srivastava RK. Oncogene; 2001 Apr 19; 20(17):2122-33. PubMed ID: 11360196 [Abstract] [Full Text] [Related]
14. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. Frese S, Frese-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA. Cancer Res; 2006 Jun 01; 66(11):5867-74. PubMed ID: 16740726 [Abstract] [Full Text] [Related]
15. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential. Hotta T, Suzuki H, Nagai S, Yamamoto K, Imakiire A, Takada E, Itoh M, Mizuguchi J. J Orthop Res; 2003 Sep 01; 21(5):949-57. PubMed ID: 12919886 [Abstract] [Full Text] [Related]
16. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Izeradjene K, Douglas L, Delaney AB, Houghton JA. Cancer Res; 2004 Nov 01; 64(21):8036-44. PubMed ID: 15520213 [Abstract] [Full Text] [Related]
17. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Walczak H, Bouchon A, Stahl H, Krammer PH. Cancer Res; 2000 Jun 01; 60(11):3051-7. PubMed ID: 10850456 [Abstract] [Full Text] [Related]
18. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways. Shankar S, Singh TR, Fandy TE, Luetrakul T, Ross DD, Srivastava RK. Int J Mol Med; 2005 Dec 01; 16(6):1125-38. PubMed ID: 16273296 [Abstract] [Full Text] [Related]
19. Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathway. He Q, Lee DI, Rong R, Yu M, Luo X, Klein M, El-Deiry WS, Huang Y, Hussain A, Sheikh MS. Oncogene; 2002 Apr 18; 21(17):2623-33. PubMed ID: 11965535 [Abstract] [Full Text] [Related]
20. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Singh TR, Shankar S, Chen X, Asim M, Srivastava RK. Cancer Res; 2003 Sep 01; 63(17):5390-400. PubMed ID: 14500373 [Abstract] [Full Text] [Related] Page: [Next] [New Search]